|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1999-12-8
|
|
pubmed:abstractText |
: At least half of patients with chronic hepatitis C virus (HCV) fail to respond to interferon or interferon/ribavirin therapy. Histological improvement is observed in some nonresponders. We conducted a randomized, controlled trial to determine if maintenance interferon therapy could prevent histological progression in this subset of nonresponders.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0016-5085
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
117
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1164-72
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10535880-Alanine Transaminase,
pubmed-meshheading:10535880-Antiviral Agents,
pubmed-meshheading:10535880-DNA, Viral,
pubmed-meshheading:10535880-Female,
pubmed-meshheading:10535880-Hepacivirus,
pubmed-meshheading:10535880-Hepatitis C, Chronic,
pubmed-meshheading:10535880-Humans,
pubmed-meshheading:10535880-Interferon-alpha,
pubmed-meshheading:10535880-Liver,
pubmed-meshheading:10535880-Male,
pubmed-meshheading:10535880-Middle Aged,
pubmed-meshheading:10535880-Prospective Studies,
pubmed-meshheading:10535880-Recombinant Proteins,
pubmed-meshheading:10535880-Viremia
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia.
|
|
pubmed:affiliation |
Hepatology Section, Medical College of Virginia Commonwealth University, Richmond, Virginia, USA. mshiffma@hsc.vcu.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
